Moreover, these analyses have already been done in conventional meta-analyses, showing for SGLT-2 inhibitors the lack of significant difference in the reduced risk of the composite outcome (CV death + HHF) in patients with or without type 2 diabetes or in subjects of 65 years of age or younger vs those older than 65 years of age [13]
This does not mean the medicine is harming the heart, but it can be confusing or scary
Over the course of treatment, the study participants lost weight, their cardiometabolic parameters improved and their free testosterone levels which tend to be elevated in women with PCOS decreased
Appropriate candidates for exploratory GLP-1 treatment with attention to mood/attention benefits typically have weight-related comorbidities, adequate psychiatric stability on current regimens, and realistic expectations about limited evidence
Among these concerns is whether semaglutide could be linked to appendicitisa serious condition characterized by an inflamed and infected appendix, often necessitating surgery
But the LillyDirect Zepbound offer is for vials that patients inject themselves with, using an old-fashioned syringe
